Mohamed El-Shahawy
Overview
Explore the profile of Mohamed El-Shahawy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang C, Orr C, Hacker-Stratton J, El-Shahawy M, Omori K, Qi M, et al.
Cell Transplant
. 2025 Jan;
34:9636897241310989.
PMID: 39881535
Although islet transplantation is effective in reducing severe hypoglycemia events and controlling blood glucose in patients with type 1 diabetes, maintaining islet graft function long-term is a significant challenge. Islets...
2.
Orr C, Stratton J, El-Shahawy M, Forouhar E, Peng A, Singh G, et al.
Cell Transplant
. 2025 Jan;
34():9636897241309412.
PMID: 39780302
Herein, we characterized the percentage of tacrolimus to the combined sirolimus and tacrolimus trough levels (tacrolimus %) observed during islet transplant-associated immune suppression therapy with post-transplant skin cancer. Although trough...
3.
Fishbane S, Pollock C, El-Shahawy M, Escudero E, Rastogi A, Pham Van B, et al.
J Am Soc Nephrol
. 2022 Apr;
33(4):850-866.
PMID: 35361724
Background: Concerns regarding cardiovascular safety with current treatments for anemia in patients with dialysis-dependent (DD)-CKD have encouraged the development of alternatives. Roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, stimulates...
4.
Kandeel F, El-Shahawy M, Singh G, Dafoe D, Isenberg J, Riggs A
Cell Transplant
. 2021 Nov;
30:9636897211057130.
PMID: 34757859
Allocation of donated organs for transplantation is a complex process that considers numerous factors such as donor, organ and candidate characteristics and practical issues such as geography. Whole pancreas and...
5.
Aslamy A, Oh E, Ahn M, Moin A, Chang M, Duncan M, et al.
J Clin Endocrinol Metab
. 2018 Mar;
103(5):1966-1976.
PMID: 29506054
Context: Efforts to preserve β-cell mass in the preclinical stages of type 1 diabetes (T1D) are limited by few blood-derived biomarkers of β-cell destruction. Objective: Platelets are proposed sources of...
6.
Gadallah M, El-Shahawy M, Andrews G, Torres-Rivera C, Hanna D, Blatt M, et al.
Hemodial Int
. 2017 Apr;
5(1):59-65.
PMID: 28452450
Animal studies indicate that insulin resistance and glucose intolerance leading to dyslipidemia in uremic rats are associated with increased cytosolic calcium ([Ca i]). The resistance and intolerance are reversed with...
7.
Qi M, Valiente L, McFadden B, Omori K, Bilbao S, Juan J, et al.
Transplant Direct
. 2015 Jul;
1(4).
PMID: 26146662
Background: We evaluated three commercially available enzymes for pancreatic digestion by comparing key parameters during the islet isolation process, as well as islet quality post-isolation. Methods: Retrospectively compared and analyzed...
8.
Orr C, Stratton J, Rao I, Al-Sayed M, Smith C, El-Shahawy M, et al.
Cell Transplant
. 2015 Apr;
25(1):83-95.
PMID: 25853639
A mathematical nonlinear regression model of several parameters (baseline insulin intake, posttransplant 2-h postprandial blood glucose, and stimulated C-peptide) from type 1 diabetics with HbA1c <6.5% who do not require...
9.
Qi M, Luis V, Bilbao S, Omori K, Rawson J, McFadden B, et al.
Am J Physiol Endocrinol Metab
. 2014 Dec;
308(5):E362-9.
PMID: 25537495
Organs from hypernatremia (elevated Na+) donors when used for transplantation have had dismal outcomes. However, islet isolation from hypernatremic donors for both transplantation and research applications has not yet been...
10.
Zabaneh R, Roger S, El-Shahawy M, Roppolo M, Runyan G, ONeil J, et al.
Perit Dial Int
. 2014 Mar;
35(4):481-9.
PMID: 24584613
Unlabelled: ♦ Background: Peginesatide is a novel, synthetic, peptide-based pegylated erythropoiesis-stimulating agent that is designed specifically to stimulate the erythropoietin receptor. The purpose of the present study was to assess,...